Restylane-L®
Restylane-L® is a medical device with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
RHA® 3 Versus Restylane-L® for Lip Augmentation
Prospective Evaluation of Facial Cosmetic Procedures
Efficacy and Safety of Injection With VINCI Plus Hyaluronic Acid Filler
Restylane-L for Correction of Infraorbital Hollows
Clinical Trials (7)
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
RHA® 3 Versus Restylane-L® for Lip Augmentation
Prospective Evaluation of Facial Cosmetic Procedures
Efficacy and Safety of Injection With VINCI Plus Hyaluronic Acid Filler
Restylane-L for Correction of Infraorbital Hollows
A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement
Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7